Noninfectious uveitis: Meeting the challenge

July 06, 2020

Chronic cases can be difficult for retina specialists; treatment is satisfying.

Ongoing study evaluates sirolimus as therapeutic option for uveitis

March 08, 2019

Inhibition plays role in autoimmune-based inflammation; has unique mechanism of action

Biologics may offer systemic therapy option for uveitis

March 07, 2019

One biologic response modifier has indication for uveitis; several in development to gain FDA approval

Adalimumab efficacious for uveitis regardless of disease duration

March 07, 2019

Quiescence, steroid-free quiescence achieved in VISUAL III trial

Sustained-release corticosteroid expands armamentarium for uveitis

March 07, 2019

FA implant effective in lowering recurrence rates through available 6, 12 months of follow-up